Research Group Translational Neuroscience

From fundamental research to integrative care concepts

The Translational Neuroscience group, led by Prof. Rejko Krüger, aims at identifying new biomarkers and therapeutic targets for Parkinson’s disease.

A glimpse into our research

We investigate mechanisms of neurodegeneration and define first entry points to screen for disease-modifying compounds using patient-derived induced pluripotent stem cells for developing strategies on precision medicine.

The clinical research focus is part of the National Centre for Excellence in Research on Parkinson’s Disease (NCER-PD), supported by the Luxembourg National Research fund (FNR).